Literature DB >> 10751286

Potent protective effects of melatonin on experimental spinal cord injury.

T Fujimoto1, T Nakamura, T Ikeda, K Takagi.   

Abstract

STUDY
DESIGN: Experimental biochemical, behavioral, and histologic investigations of spinal cord injury in rats.
OBJECTIVE: To investigate the effects of melatonin, a pineal hormone, in compression ischemic-induced spinal cord injury. SUMMARY OF BACKGROUND DATA: The implication of activated neutrophils in the worsening of spinal cord injury has been shown. Melatonin was shown to play an important role in protecting animal cells from neutrophil-induced toxicity and damage by free radicals. There is no report on using melatonin for spinal cord injury.
METHODS: Spinal cord injury was induced by placing 25 g of weight extradurally on the rat spinal cord at T12 for 20 minutes. The rats were randomly divided into three groups. Sham rats had only laminectomy. Melatonin rats were injected with melatonin (2.5 mg/kg) intraperitoneally (intraperitoneal) five times: at 5 minutes, then 1, 2, 3, and 4 hours after the injury. Correspondingly, the control rats were injected with saline. Measured levels of lipid peroxidation estimated thiobarbituric acid reactive substances (TBARS) and the accumulation of leukocytes at the site of trauma, which were evaluated by measuring tissue myeloperoxidase activity. The recovery was assessed by using three clinical scoring systems, and histologic changes of the damaged spinal cord were examined.
RESULTS: The thiobarbituric acid reactive substances content in the spinal cord increased after the injury, with two peaks (at 1 and 4 hours), and nitrogen mustard-induced leukocytopenia significantly attenuated the thiobarbituric acid reactive substances content in four 4 after injury. Also in these 4 hours, myeloperoxidase activity increased and melatonin injection reduced thiobarbituric acid reactive substances content and myeloperoxidase activity, which attenuated the motor deficits as well. Histologic findings showed that the melatonin group had less cavity formation than the control group.
CONCLUSION: Results showed that injection of melatonin reduced thiobarbituric acid reactive substances content and myeloperoxidase activity, facilitating recovery of the damaged spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751286     DOI: 10.1097/00007632-200004010-00003

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  18 in total

1.  Protective effect of a new hypothalamic peptide against cobra venom and trauma-induced neuronal injury.

Authors:  A A Galoyan; J S Sarkissian; T K Kipriyan; E J Sarkissian; E A Chavushyan; R M Sulkhanyan; I B Meliksetyan; S S Abrahamyan; Z A Avetisyan; N A Otieva
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

3.  Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses.

Authors:  Yasemin Kaya; Levent Sarıkcıoğlu; Mutay Aslan; Ceren Kencebay; Necdet Demir; Narin Derin; Doychin N Angelov; Fatoş Belgin Yıldırım
Journal:  Childs Nerv Syst       Date:  2012-10-09       Impact factor: 1.475

4.  Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord.

Authors:  Gholam Hassan Haddadi; Reza Fardid
Journal:  Rep Pract Oncol Radiother       Date:  2015-02-21

5.  The effect of melatonin on spinal cord after ischemia in rats.

Authors:  S Aydemir; D Dogan; A Kocak; N Dilsiz
Journal:  Spinal Cord       Date:  2015-12-01       Impact factor: 2.772

Review 6.  Antioxidant therapies in traumatic brain and spinal cord injury.

Authors:  Mona Bains; Edward D Hall
Journal:  Biochim Biophys Acta       Date:  2011-11-04

7.  Circadian variations in melatonin and cortisol in patients with cervical spinal cord injury.

Authors:  G Fatima; V P Sharma; N S Verma
Journal:  Spinal Cord       Date:  2015-11-17       Impact factor: 2.772

8.  Changes in vascularity of cartilage endplate of degenerated intervertebral discs in response to melatonin administration in rats.

Authors:  Mehmet Turgut; Serap Uslu; Ayşegül Uysal; Mine Ertem Yurtseven; Hatice Ustün
Journal:  Neurosurg Rev       Date:  2003-05       Impact factor: 3.042

9.  Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.

Authors:  Suleyman R Cayli; Ayhan Kocak; Ugur Yilmaz; Ayhan Tekiner; Mine Erbil; Cetin Ozturk; Kadir Batcioglu; Saim Yologlu
Journal:  Eur Spine J       Date:  2004-07-01       Impact factor: 3.134

Review 10.  Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury.

Authors:  Shushi Kabu; Yue Gao; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2015-09-04       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.